Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreAccelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreYour world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
Learn MoreFor government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
Learn MoreA curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREGet the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
LEARN MORESome of the most innovative and efficacious new products being launched are cell and gene therapies. However, healthcare systems globally are not set up to properly capture the value of these therapies given most are single-use, and have high upfront cost, uncertain durability of effect, and are not proven consistently safe.
Key objectives:
Rob Glik
VP and GM, Value & Access Strategy Consulting, IQVIA
Justin DiSanto
Principal, Value & Access Strategy Consulting, IQVIA
